Spectrum of β-Thalassemia and Other Hemoglobinopathies in the Saurashtra Region of Gujarat, India: Analysis of a Large Population Screening Program

References

• Weatherall DJ. The inherited diseases of hemoglobin are an emerging global health burden. Blood. 2010;115(22):4331–4336.
   PubMed Web of Science ®Google Scholar
• Colah R, Italia K, Gorakshakar A. Burden of thalassemia in India: the road map for control. Pediatr Hematol Oncol J. 2017;2(4):79–84.
   Google Scholar
• Mentzer WC. Jr. Differentiation of iron deficiency from thalassaemia trait. Lancet. 1973;1(7808):882.
   PubMed Web of Science ®Google Scholar
• Shine I, Lal S. A strategy to detect beta-thalassaemia minor. Lancet. 1977;1(8013):692–694.
   PubMed Web of Science ®Google Scholar
• Grow K, Vashist M, Abrol P, et al. Beta thalassemia in India: current status and the challenges ahead. Int J Pharm Pharmaceut Sci. 2014;6(4):28–33.
   Google Scholar
• Moirangthem A, Phadke SR. Socio-demographic profile and economic burden of treatment of transfusion dependent thalassemia. Indian J Pediatr. 2018;85(2):102–107.
   PubMed Web of Science ®Google Scholar
• Mohanty D, Colah RB, Gorakshakar AC, et al. Prevalence of β-thalassemia and other haemoglobinopathies in six cities in India: a multicentre study. J Community Genet. 2013;4(1):33–42.
   PubMedGoogle Scholar
• Bhukhanvala DS, Sorathiya SM, Sawant P, et al. Antenatal screening for identification of couples for prenatal diagnosis of severe hemoglobinopathies in Surat, South Gujarat. J Obstet Gynaecol India. 2013;63(2):123–127.
   PubMedGoogle Scholar
• Patel AG, Shah AP, Sorathiya SM, et al. Hemoglobinopathies in South Gujarat population and incidence of anemia in them. Indian J Hum Genet. 2012;18(3):294–298.
   PubMedGoogle Scholar
• Choudhuri S, Sen A, Ghosh MK, et al. Effectiveness of prenatal screening for hemoglobinopathies in a developing country. Hemoglobin. 2015;39(6):380–383.
   PubMed Web of Science ®Google Scholar
• Chatterjee T, Chakravarty A, Chakravarty S. Population screening and prevention strategies for thalassemias and other hemoglobinopathies of eastern India: Experience of 18,166 cases. Hemoglobin. 2015;39(6):384–388.
   PubMed Web of Science ®Google Scholar
• Mondal SK, Mandal S. Prevalence of thalassemia and hemoglobinopathy in eastern India: a 10-year high-performance liquid chromatography study of 119,336 cases. Asian J Transfus Sci. 2016;10(1):105–110.
   PubMedGoogle Scholar
• Mendiratta SL, Mittal M, Naaz F, et al. Role of thalassemia screening in prevention and control of thalassemia-a 5 year experience. Int J Reprod Contracept Obstet Gynecol. 2017;5(9):3107–3111.
   Google Scholar
• Patel AP, Naik MR, Shah NM, et al. Prevalence of common hemoglobinopathies in Gujarat: an analysis of a large population screening program. Natl J Community Med. 2012;3(01):112–116.
   Google Scholar
• Sorathiya VP, Vachhani NA, Nandani SL, et al. Experience with NESTROFT for screening for thalassemia trait/minor: evaluation against CBC and HPLC in a high prevalence region in Saurashtra, Gujarat, India. Int J Res Med Sci. 2020;8(3):1108–1113.
   Google Scholar
• Colah R, Gorakshakar A, Phanasgaonkar S, et al. Epidemiology of beta-thalassaemia in Western India: mapping the frequencies and mutations in sub-regions of Maharashtra and Gujarat. Br J Haematol. 2010;149(5):739–747.
   PubMed Web of Science ®Google Scholar
• Madan N, Sharma S, Sood SK, et al. Frequency of β-thalassemia trait and other hemoglobinopathies in northern and western India. Indian J Hum Genet. 2010;16(1):16–25.
   PubMedGoogle Scholar
• Mandal PK, Maji SK, Dolai TK. Present scenario of hemoglobinopathies in West Bengal, India: an analysis of a large population. Int J Med Public Health. 2014;4(4):496–499.
   Google Scholar
• Pandey S, Mishra RM, Pandey S, et al. Molecular characterization of hemoglobin D Punjab traits and clinical-hematological profile of the patients. Sao Paulo Med J. 2012;130(4):248–251.
   PubMed Web of Science ®Google Scholar
• Colah R, Mukherjee M, Ghosh K. Sickle cell disease in India. Curr Opin Hematol. 2014;21(3):215–223.
   PubMed Web of Science ®Google Scholar
• Singh AK. Spectrum of hemoglobinopathies in the state of Orissa: a ten years cohort study. J Assoc Phys India. 2006;54:159–160.
   PubMedGoogle Scholar
• Vehapoglu A, Ozgurhan G, Demir AD, et al. Hematological indices for differential diagnosis of beta thalassemia trait and iron deficiency anemia. Anemia. 2014;2014:576738.
   PubMedGoogle Scholar
• Bhushan R, Shukla S, Singh D, et al. Reliability of different RBC indices to differentiate between beta thalassemia trait and iron deficiency anemia during antenatal screening. World J Pathol. 2018;7(3):14–20.
   Google Scholar
• Rosnah B, Shahida NS, Mohd NH, et al. The diagnosis of β thalassemia with borderline HbA2 level among Kelantan population. J Blood Disord Transf. 2017;8(5):396–389.
   Google Scholar
• Nadkarni AH, Gorakshakar AC, Sawant PM, et al. The phenotypic and molecular diversity of hemoglobinopathies in India: a review of 15 years at a referral center. Int J Lab Hematol. 2019;41(2):218–226.
   PubMed Web of Science ®Google Scholar
• Dhawle M, Methwani A, Tangde A, et al. HbQ-India: an uncommon hemoglobin variant. Int J Res Med Sci. 2018;6(5):1687–1690.
   Google Scholar
• Warghade S, Britto J, Haryan R, et al. Prevalence of hemoglobin variants and hemoglobinopathies using cation-exchange high-performance liquid chromatography in central reference laboratory of India: a report of 65779 cases. J Lab Physicians. 2018;10(1):73–79.
   PubMed Web of Science ®Google Scholar
• Chandel RS, Roy A, Abichandani LG. Serendipity: a rare discovery of Haemoglobin D-Iran in an Indian female during routine antenatal screening for β-thalassemia. J Clin Diagn Res. 2015;9(7):BD01–BD02.
   PubMedGoogle Scholar